Skip to content
MedsAcross

Alternatives

Alternatives to Myrbetriq 50 mg extended-release tablet

2 other presentations of Mirabegron 50 mg extended-release tablet

There are 2 alternatives to this medicine in the catalogue: the same active ingredient (Mirabegron), strength (50 mg) and dosage form (extended-release tablet) from 2 other makers or registers. The table compares packs, storage, lead time, documents and availability.

Side by side

The first row is the medicine you came from.

MedicineManufacturerRegisterPacksStorageLead timeDocumentsAvailability
Myrbetriq 50 mg extended-release tabletThis pageOralAstellas PharmaUS FDA1 bottle, 1 bottleStore and Dispense Store at 20°C to 25°C (68°F to 77°F) with excursions permitted from 15°C to 30°C (59°F to 86°F). logo.jpg logo.jpg MYRBETRIQ Granules (mirabegron for extended-release oral suspension) MYRBETRIQ Granules (mirabegron for extended-release oral suspension) is supplied as granules in bottles with a child-resistant cap packaged in an aluminum pouch with desiccant.On request—Available on request
Mirabegron 50 mg extended-release tabletOral—US FDA100 tablets, 30 tabletsStore and Dispense Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C to 30°C (59°F to 86°F). 1On request—Available on request
Mirabgeorn 50 mg extended-release tabletOralQilu PharmaceuticalUS FDA30 tablets, 90 tabletsStore and Dispense Store at 20°C to 25°C (68°F to 77°F) with excursions permitted from 15°C to 30°C (59°F to 86°F).On request—Available on request

Alternatives are listed for sourcing. Whether one medicine can replace another is the prescriber's decision, under the rules of the destination country.

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Back to Myrbetriq 50 mg extended-release tablet

Not sure which maker to choose?

Request a quote for the medicine and we will propose the options that fit your country's import rules and timelines.